These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 9613717

  • 1. Iron metabolism and Parkinson's disease.
    Hirsch EC, Faucheux BA.
    Mov Disord; 1998; 13 Suppl 1():39-45. PubMed ID: 9613717
    [Abstract] [Full Text] [Related]

  • 2. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P.
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [Abstract] [Full Text] [Related]

  • 3. What process causes nigral cell death in Parkinson's disease?
    Jenner P.
    Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
    [Abstract] [Full Text] [Related]

  • 4. Iron transport in Parkinson's disease.
    Hirsch EC.
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
    [Abstract] [Full Text] [Related]

  • 5. The possible role of iron in the etiopathology of Parkinson's disease.
    Youdim MB, Ben-Shachar D, Riederer P.
    Mov Disord; 1993 Dec; 8(1):1-12. PubMed ID: 8419792
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S.
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [Abstract] [Full Text] [Related]

  • 7. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.
    Floor E.
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):709-20. PubMed ID: 10875434
    [Abstract] [Full Text] [Related]

  • 8. [Iron homeostasis and Parkinson's disease].
    Faucheux BA, Hirsch EC.
    Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():23-30. PubMed ID: 9827211
    [No Abstract] [Full Text] [Related]

  • 9. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
    Andersen JK.
    Novartis Found Symp; 2001 Jul; 235():11-20; discussion 20-5. PubMed ID: 11280021
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of Parkinson's disease.
    Schapira AH.
    Baillieres Clin Neurol; 1997 Apr; 6(1):15-36. PubMed ID: 9426866
    [Abstract] [Full Text] [Related]

  • 11. Individual dopaminergic neurons show raised iron levels in Parkinson disease.
    Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM.
    Neurology; 2007 May 22; 68(21):1820-5. PubMed ID: 17515544
    [Abstract] [Full Text] [Related]

  • 12. Iron and ferritin in substantia nigra in Parkinson's disease.
    Jellinger KA, Kienzl E, Rumpelmaier G, Paulus W, Riederer P, Stachelberger H, Youdim MB, Ben-Shachar D.
    Adv Neurol; 1993 May 22; 60():267-72. PubMed ID: 8420142
    [No Abstract] [Full Text] [Related]

  • 13. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
    Fahn S, Cohen G.
    Ann Neurol; 1992 Dec 22; 32(6):804-12. PubMed ID: 1471873
    [Abstract] [Full Text] [Related]

  • 14. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov 22; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 15. [Oxidative stress and the brain].
    Tanaka M.
    Nihon Ronen Igakkai Zasshi; 1997 Sep 22; 34(9):706-10. PubMed ID: 9430979
    [Abstract] [Full Text] [Related]

  • 16. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
    Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T.
    J Neurochem; 2008 Aug 22; 106(4):1866-75. PubMed ID: 18624918
    [Abstract] [Full Text] [Related]

  • 17. [Current views on the mechanisms of dopaminergic neuron death of the nigrostriatal system in Parkinson's disease].
    Bertrand E, Lechowicz W, Szpak GM, Dymecki J.
    Neurol Neurochir Pol; 1997 Aug 22; 31(2):295-302. PubMed ID: 9380259
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH, Kupsch A.
    Curr Opin Neurol Neurosurg; 1993 Jun 22; 6(3):323-32. PubMed ID: 8507901
    [Abstract] [Full Text] [Related]

  • 19. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
    Jenner P.
    Acta Neurol Scand Suppl; 1993 Jun 22; 146():6-13. PubMed ID: 8333254
    [Abstract] [Full Text] [Related]

  • 20. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB, Ben-Shachar D, Riederer P.
    J Neural Transm Suppl; 1994 Jun 22; 43():113-22. PubMed ID: 7884393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.